Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA; email:
Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Annu Rev Pathol. 2020 Jan 24;15:23-50. doi: 10.1146/annurev-pathmechdis-012419-032824. Epub 2019 Aug 9.
The liver is a complex organ performing numerous vital physiological functions. For that reason, it possesses immense regenerative potential. The capacity for repair is largely attributable to the ability of its differentiated epithelial cells, hepatocytes and biliary epithelial cells, to proliferate after injury. However, in cases of extreme acute injury or prolonged chronic insult, the liver may fail to regenerate or do so suboptimally. This often results in life-threatening end-stage liver disease for which liver transplantation is the only effective treatment. In many forms of liver injury, bipotent liver progenitor cells are theorized to be activated as an additional tier of liver repair. However, the existence, origin, fate, activation, and contribution to regeneration of liver progenitor cells is hotly debated, especially since hepatocytes and biliary epithelial cells themselves may serve as facultative stem cells for one another during severe liver injury. Here, we discuss the evidence both supporting and refuting the existence of liver progenitor cells in a variety of experimental models. We also debate the validity of developing therapies harnessing the capabilities of these cells as potential treatments for patients with severe and chronic liver diseases.
肝脏是一个执行多种重要生理功能的复杂器官。正因为如此,它具有巨大的再生潜力。修复能力在很大程度上归因于其分化的上皮细胞,即肝细胞和胆管上皮细胞,在损伤后能够增殖。然而,在极急性损伤或长期慢性损伤的情况下,肝脏可能无法再生或无法最优地再生。这通常会导致危及生命的终末期肝病,肝移植是唯一有效的治疗方法。在许多形式的肝损伤中,双潜能肝祖细胞被认为是作为肝脏修复的另一层被激活的。然而,肝祖细胞的存在、起源、命运、激活及其对再生的贡献仍存在争议,尤其是因为在严重肝损伤期间,肝细胞和胆管上皮细胞本身可能作为多功能干细胞相互作用。在这里,我们讨论了在各种实验模型中支持和反驳肝祖细胞存在的证据。我们还讨论了利用这些细胞的能力开发治疗方法作为严重和慢性肝病患者潜在治疗方法的有效性。